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Minimal hepatic dysfunction can be common in acute 
Q fever, but severe acute cholestatic hepatitis is rare-
ly reported. We report on a 55-year-old male with 
acute Q fever and severe acute cholestatic hepatitis. 
He complained of fever, jaundice, ascites, and rest-
lessness on admission. A liver biopsy revealed the 
presence of compact fibrin-ring granulomas. Serologic 
titers for C. burnetii IgM and IgG were 2048:1 and 
1024:1, respectively. C. burnetii DNA was detected by 
a nested polymerase chain reaction on the liver 
tissue. (Gut and Liver 2009;3:141-144)
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INTRODUCTION
  Q fever is a worldwide zoonosis caused by Coxiella bur-
netii, a strictly intracellular gram-negative bacterium. The 
common reservoirs for C. burnetii are cattle, sheep, and 
goats. Humans are infected by the inhalation of con-
taminated aerosol and dusts derived from infected animal 
products such as placenta, feces, and urines. The in-
cubation period of the disease is 2-3 weeks after 
exposure. The clinical presentation of Q fever poly-
morphic is nonspecific and may be divided into acute and 
chronic Q fever.
1 The former most commonly presents it-
self as a self-limited febrile illness and subclinical 
hepatitis. Elevated levels of the hepatic enzyme range 
from twice to four-fold the highest reference value. Severe 
clinical forms of acute Q fever are meningitis, me-
ningoencephalitis, myocarditis and pericarditis.
2 Organs 
are not usually seriously affected, and the overall prog-
nosis is excellent except for those with myocarditis or 
meningoencephalitis.
3,4 Hepatic complication of acute Q 
fever, such as a severe acute cholestatic hepatitis has un-
til now never been reported in Korea. Therefore, we re-
port a case of acute Q fever with a severe acute choles-
tatic hepatitis. 
CASE REPORT
  A 55-year-old male who was previously healthy was re-
ferred to a gastroenterologist for evaluation and treatment 
of unknown hepatitis with marked hyperbilirubinemia. He 
complained of striking fever, chills and myalgia that had 
started two weeks earlier. And his illness such as 
dark-colored urine, swelling of the leg, abdominal dis-
tension, anxiety, insomnia and restlessness had com-
m e n c e d  f i v e  d a y s  b e f o r e  h o s p i t a l i z a t i o n .  H e  h a d  n o  s i g -
nificant medical history. He did not smoke, drink, or take 
any herbal medicine. He did not suffer any trauma, either. 
Upon physical examination, his body temperature was 
40.2
oC, his pulse rate was 102/min, his respiratory rate 
was 24/min and his blood pressure was 140/79 mmHg. 
Upon neurologic exam ination, there were no focal neuro-
logic and diffuse meningeal irritation signs. Both scleras 
were markedly icteric. A systolic murmur (Grade II) was 
heard in the anterior chest, but the breathing sound was 
clear. Diffuse abdominal tenderness but no rebounding 
tenderness was noted in the abdomen. Pitting edema was 
present in bilateral pretibial regions. Laboratory tests re-
vealed that the white blood cell count was 12,700/mm
3 
(neutrophils of 83%, lymphocyte of 9.3%), hemoglobin 
was 11.5 g/dL and platelets were 241,000/mm
3. Liver 
function test showed alanine transaminase (ALT) of 102 
IU/L, aspartic acid transaminase (AST) of 131 IU/L, alka-142   Gut and Liver, Vol. 3, No. 2, June 2009
Fig. 1. Microscopic findings. The liver core biopsy sample 
demonstrates distinctive fibrin-ring granulomas (arrows), 
showing central lipid cores, eosinophilic ring of fibrin, and 
mixed infiltrate of histiocytes, lymphocytes, and neutrophils
(H&E, ×400).
line phosphatase of 265 IU/L, total bilirubin of 22.5 
mg/dL, direct bilirubin of 20.2 mg/dL, albumin of 2.3 
g/dL and creatinine of 1.1 mg/dL. Prothrombin time (PT 
INR) was 1.28 (control 0.8-1.2) and activated partial 
thrombin time (aPTT) was 53.6 s (control, 29-45). C-re-
active protein w as 14.91 m g/dL. A serology test for hep-
atitis A, B, C and E was negative, and a test for 
Epstein-Barr virus and Cytomegalovirus indicated previous 
infections. Antibodies for human immunodeficiency virus 
type 1 (HIV-1) and VDRL were negative. A test for anti-
mitochondrial antibodies, antinuclear antibodies and anti-
smooth muscle antibody was negative. A chest X-ray on 
the first day of hospitalization was normal. Abdominal 
computed tomography (CT) revealed a small amount of 
ascites and mild hepatomegaly. Magnetic resonance chol-
angiography (MRCP) was performed and exhibited no 
stone and no evidence of biliary tract obstruction. There 
was no growth in the blood cultures. An electrocardio-
gram was normal, and echocardiography showed no 
vegetation. Under the impression of the severe acute cho-
lestatic hepatitis associated with a fever of unknown ori-
gin, a transjugular liver biopsy was done. Microscopic ex-
amination revealed numerous compact fibrin-ring gran-
ulomas (Fig. 1), characterized by a central, round, clear 
space surrounded by an eosinophilic fibrin ring and in-
filtrated by histiocytes, lymphocytes, and neutrophils. 
Considering his history carefully, one month ago he had 
eaten uncooked goat meat and ingested its blood. 
Therefore, an empirical trial was done by administering 
doxycycline 200 mg daily for 2 weeks. A concurrent sero-
logic test for C. burnetii immunoglobulin M (IgM) and G 
(IgG) was done. Symptoms of cholestatic hepatitis had 
subsided for three days after taking doxycycline. A sig-
nificant rise in the titers of IgM and IgG antibodies 
against C. burnetii were 2048:1 and 1024:1, respectively. A 
polymerase chain reaction (PCR) was done on the liver 
tissue specimen and identified the presence of C. burnetii 
DNA. After discharge, he had visit at out-patient depart-
ment one month later, the liver function tests were nor-
mal and he had completely recovered.
DISCUSSION
  Common manifestations of acute Q fever usually pres-
ent an influenza-like illness with a varying degree of 
pneumonia and hepatitis. The most frequent clinical pre-
sentation of acute Q fever may vary from one area to 
another. Indeed, acute Q fever hepatitis has been reported 
in 9.0% to 67% in the endemic area, such as the south of 
Spain, Ontario, and France. Clinical and laboratory find-
ings of acute Q fever hepatitis are a mild elevation of liv-
er enzymes, hepatomegaly, and/or splenomegaly, which 
have been reported in 55-67%, 16-54% and 14-23% re-
spectively. Jaundice, in 3-5%, is a rare clinical feature of 
acute Q fever hepatitis.
5,6 In this case, acute Q fever pre-
sented a severe hepatitis with a marked hyperbiliru-
binemia (Total bilirubin ＞20 mg/dL) and ascites. These 
characteristic findings were different from previous 
reports. In southern Taiwan, Chang et al. have reported 
that total serum bilirubin ranged from 2 to 18.7 mg/dL. 
The total bilirubin of the two patients from the above pa-
per was above 10 mg/dL. In one patient, acute chol-
ecystitis with empyema formatiom was suspected initially. 
An exploratory laparotomy was performed and a T tube 
was inserted in the gallbladder.
    The other was initially diagnosed with cholelithiasis 
with acute cholangitis. Endoscopic retrograde cholangio-
pancreatography with endoscopic nasobiliary drainage was 
done.
7 In France, seven cases of acute acalculous chol-
ecystitis associated with Q fever have been reported. 
According to the French report, three patients have symp-
toms of jaundice, and a cholecystectomy was performed 
in five of the patients within two or three days of their 
admission.
8 In this case, the biliary tract and gallbladder 
were relatively normal in appearance. Consequently, 
marked hyperbilirubinemia and ascites result from severe 
hepatic dysfunction and not from obstructive causes. 
Although the correlation between the bilirubin level and 
the severity of acute Q fever hepatitis is unclear, it may 
prolong days of hospitalization, febrile duration and 
recovery.
7 H o w e v e r ,  s i n c e  n e u r o l o g i c  s y m p t o m s  i n  a c u t e  
Q fever have been reported less frequently, a clinical sus-
picion of neurologic involvement is very important in or-Choi HC, et al: A Case of Acute Q Fever with Severe Acute Cholestatic Hepatitis   143
der to rule out meningoencephalitis. Symptoms that 
arouse suspicion are severe headaches that are strong 
enough to prompt a lumbar puncture to rule out menin-
gitis and progressive focal neurologic signs.
9 In th is case, 
he did not complain of headaches. There was no me-
ningeal irritation or progressive focal neurologic signs. 
Although behavioral abnormalities were common in the 
meningoencephalitis, they were nonspecific. Therefore, it 
i s  m o r e  l i k e l y  t h a t  s y m p t o m s  s u c h  a s  a n x i e t y ,  i n s o m n i a ,  
and restlessness result from severe acute cholestatic hep-
atitis and not from meningoencephalitis. It is true that 
the pathogenic mechanisms and interaction of C. burnetii 
with the host’s immune systems are still poorly under-
stood, but hematogenous spread of C. burnetii results in 
infection of the liver, spleen, bone marrow and re-
productive tract, causing the formation of granulomatous 
lesions.
10 There are three types of granulomatous lesions: 
clear central space with fibrinoid ring type, containing fi-
brin without a ring configuration type and nonspecific 
type.
11 The granulomas of Q fever are histologically char-
acterized by clear central space with fibrinoid ring type. 
These granulomas are thought to be characteristic of Q 
fever hepatitis.
12 Also, clear central space with fibrinoid- 
ring type graulomas have also been described in patients 
with leishmaniasis, infectious mononucleosis, giant cell 
arteritis, and allopurinol hypersensitivity.
13-16 Recently, it 
has been noted in chronic hepatitis C and acute hepatitis 
A.
17,18 In this case, the biopsy specimen revealed that typ-
ical granuloma consists of fibrin-ring with clear central 
space. There is no evidence of neoplastic cell infiltrations 
or vasculitis. Although hepatic fibrin-ring granulomas are 
characteristic, they are not pathognomic. In fact, it is dif-
ficult to isolate C. burnetii, and infection risk is very high 
in cultures of C. burnetii. Therefore, a definitive test of in-
fection is serologically diagnosed in practice.
19 This test 
detects specific antibodies to C. burnetii by employing the 
complement fixation (CF) method or indirect immuno-
florescence (IFA) method.
20,21 In general, serologic tests 
using the IFA method are currently used because they are 
eight times more sensitive than the CF method.
22 In the 
acute phase of infection, within a few days after the onset 
of clinical symptoms, specific IgM globulins could be de-
tected, rising to peak levels in the fourth and eighth week 
and then falling in the twelfth week. This was accom-
panied by a rise in IgG in the second and third week. 
Therefore, high IgM values indicate acute infection.
23 In 
this case, a significant rise in the titers of IgM and IgG 
antibodies against C. burnetii were 2048:1 and 1024:1. 
Polymerase chain reaction (PCR)-based methods have 
been used as an additional confirmative test because iso-
lation of C. burnetii is time-consuming.
24 Macrolides are 
commonly used for the empirical treatment of richettsial 
disease. According to the study regarding the effective-
ness of macrolides in acute Q fever, the mean times until 
defervescence of doxycycline were 2.9 days.
25-27 In this 
case, an empirical therapeutic trial was done by using 
doxycycline at 200 mg daily for 2 weeks. Symptoms of 
cholestatic hepatitis had subsided rapidly after taking 
doxycycline.
  Therefore, we report a case of acute Q fever with a se-
vere acute cholestatic hepatitis.
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